Microfluidic Chip-Based Online Screening Coupled to Mass Spectrometry

Journal of Biomolecular Screening

Volumn 21, Issue 2, 2016, Pages 212-220

  Iyer, Janaki Krishnamoorthy ^a   Otvos, Reka A ^b   Kool, Jeroen ^b   Kini, R Manjunatha ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

argatroban; benzamidine; FXa inhibitor; thrombin inhibitor; thrombosis

Indexed keywords

ARGATROBAN; BENZAMIDINE; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; SNAKE VENOM; THROMBIN; THROMBIN INHIBITOR; ANTICOAGULANT AGENT;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MIXTURE; DRUG RECEPTOR BINDING; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC50; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MICHAELIS MENTEN KINETICS; MICROFLUIDIC ANALYSIS; MICROFLUIDIC CHIP BASED ONLINE SCREENING; MICROFLUIDICS; NANO LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SUBSTRATE CONCENTRATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANTAGONISTS AND INHIBITORS; BLOOD CLOTTING; CHEMISTRY; DRUG EFFECTS; ONLINE SYSTEM; PROCEDURES;

ANTICOAGULANTS; BLOOD COAGULATION; CHROMATOGRAPHY, LIQUID; FACTOR XA; FACTOR XA INHIBITORS; MASS SPECTROMETRY; MICROFLUIDICS; ONLINE SYSTEMS; THROMBIN;

EID: 84954542313     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057115602648     Document Type: Article

References (23)

1. Boon G. D., An Overview of Hemostasis. Toxicol. Pathol. 1993, 21, 170-179.
2. Borissoff J. I., Spronk H. M. H., Heeneman S., et al. Is Thrombin a Key Player in the 'Coagulation-Atherogenesis' Maze? Cardiovasc. Res. 2009, 82, 392-403.
3. Chaudhari K., Hamad B., Syed B. A., Antithrombotic Drugs Market. Nat. Rev. Drug. Discov. 2014, 3, 571-572.
4. Koh C. Y., Kini R. M., Anticoagulants from Hematophagous Animals. Expert Rev. Hematol. 2008, 1, 135-139.
5. Shi S. Y., Zhou H. H., Zhang Y. P., et al. Coupling HPLC to On-Line, Post-Column (Bio)Chemical Assays for High-Resolution Screening of Bioactive Compounds from Complex Mixtures. Trends Anal. Chem. 2009, 28, 865-877.
6. Wigglesworth M. J., Murray D. C., Blackett C. J., et al. Increasing the Delivery of Next Generation Therapeutics from High Throughput Screening Libraries. Curr. Opin. Chem. Biol. 2015, 26, 104-110.
7. Entzeroth M., Emerging Trends in High-Throughput Screening. Curr. Opin. Pharmacol. 2003, 3, 522-529.
8. Kool J., Giera M., Irth H., et al. Advances in Mass Spectrometry-Based Post-Column Bioaffinity Profiling of Mixtures. Anal. Bioanal. Chem. 2011, 399, 2655-2668.
9. Greis K. D., Mass Spectrometry for Enzyme Assays and Inhibitor Screening: An Emerging Application in Pharmaceutical Research. Mass Spectrom. Rev. 2007, 26, 324-339.
10. Graßmann J., Scheerle R. K., Letzel T., Functional Proteomics: Application of Mass Spectrometry to the Study of Enzymology in Complex Mixtures. Anal. Bioanal. Chem. 2012, 402, 625-645.
11. Giera M., Heus F., Janssen L., et al. Microfractionation Revisited: A 1536 Well High Resolution Screening Assay. Anal. Chem. 2009, 81, 5460-5466.
12. Shin Y. G., van Breemen R. B., Analysis and Screening of Combinatorial Libraries Using Mass Spectrometry. Biopharm. Drug Dispos. 2011, 22, 353-372.
13. Valenzuela J. G., Exploring Tick Saliva: From Biochemistry to 'Sialomes' and Functional Genomics. Parasitology 2004, 129, S83-S94.
14. Irth H., Continuous-Flow Systems for Ligand Binding and Enzyme Inhibition Assays Based on Mass Spectrometry, in Mass Spectrom. Med. Chem.: Appl. Drug Discov. (eds Wanner K. T., Höfner G.,), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. 2007, Ch5, 185-215.
15. de Boer A. R., Bruyneel B., Krabbe J. G., et al. A Microfluidic-Based Enzymatic Assay for Bioactivity Screening Combined with Capillary Liquid Chromatography and Mass Spectrometry. Lab Chip 2005, 5, 1286-1292.
16. Kool J., de Kloe G. E., Bruyneel B., et al. Online Fluorescence Enhancement Assay for the Acetylcholine Binding Protein with Parallel Mass Spectrometric Identification. J. Med. Chem. 2010, 53, 4720-4730.
17. Heus F., Otvos R., Aspers R. L. E. G., et al. Miniaturized Bioaffinity Assessment Coupled to Mass Spectrometry for Guided Purification of Bioactives from Toad and Cone Snail. Biology 2014, 3, 139-156.
18. Otvos R., Heus F., Vonk F. J., et al. Analytical Workflow for Rapid Screening and Purification of Bioactives from Venom Proteomes. Toxicon 2013, 76, 270-281.
19. Falck D., de Vlieger J. S. B., Niessen W. M. A., et al. Development of an Online p38α Mitogen-Activated Protein Kinase Binding Assay and Integration of LC-HR-MS. Anal. Bioanal. Chem. 2010, 398, 1771-1780.
20. Acker M. G., Auld D. S., Considerations for the Design and Reporting of Enzyme Assays in High-Throughput Screening Applications. Perspect. Sci. 2014, 1, 56-73.
21. Heus F., Giera M., de Kloe G. E., et al. Development of a Microfluidic Confocal Fluorescence Detection System for the Hyphenation of Nano-LC to On-Line Biochemical Assays. Anal. Bioanal. Chem. 2010, 398, 3023-3032.
22. Schebb N. H., Heus F., Saenger T., et al. Development of a Countergradient Parking System for Gradient Liquid Chromatography with Online Biochemical Detection of Serine Protease Inhibitors. Anal. Chem. 2008, 80, 6764-6772.
23. Zhang J. H., Chung T. D. Y., Oldenburg K. R., A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999, 4, 67-73.